HU9201768D0 - New process for the selective isolation of 2-deoxi-2,2-difluor-d-eritro-pentfuranose-1-ulose-3,5-dibensoate from enantiomeric solution - Google Patents

New process for the selective isolation of 2-deoxi-2,2-difluor-d-eritro-pentfuranose-1-ulose-3,5-dibensoate from enantiomeric solution

Info

Publication number
HU9201768D0
HU9201768D0 HU9201768A HU9201768A HU9201768D0 HU 9201768 D0 HU9201768 D0 HU 9201768D0 HU 9201768 A HU9201768 A HU 9201768A HU 9201768 A HU9201768 A HU 9201768A HU 9201768 D0 HU9201768 D0 HU 9201768D0
Authority
HU
Hungary
Prior art keywords
pentfuranose
dibensoate
eritro
deoxi
ulose
Prior art date
Application number
HU9201768A
Other languages
English (en)
Inventor
Ta-Sen Chou
Perry Clark Heath
Lawrence Edward Patterson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HU9201768D0 publication Critical patent/HU9201768D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Epoxy Compounds (AREA)
HU9201768A 1987-08-28 1992-05-27 New process for the selective isolation of 2-deoxi-2,2-difluor-d-eritro-pentfuranose-1-ulose-3,5-dibensoate from enantiomeric solution HU9201768D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
HU9201768D0 true HU9201768D0 (en) 1992-08-28

Family

ID=22224017

Family Applications (3)

Application Number Title Priority Date Filing Date
HU906268A HU206886B (en) 1987-08-28 1988-08-26 Process for producing 2,2-difluoro-lactones
HU884471A HU202249B (en) 1987-08-28 1988-08-26 New process for producing 2'-deoxy-2,2'-difluoro-nukleozides
HU9201768A HU9201768D0 (en) 1987-08-28 1992-05-27 New process for the selective isolation of 2-deoxi-2,2-difluor-d-eritro-pentfuranose-1-ulose-3,5-dibensoate from enantiomeric solution

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HU906268A HU206886B (en) 1987-08-28 1988-08-26 Process for producing 2,2-difluoro-lactones
HU884471A HU202249B (en) 1987-08-28 1988-08-26 New process for producing 2'-deoxy-2,2'-difluoro-nukleozides

Country Status (11)

Country Link
EP (4) EP0306190B1 (hu)
JP (5) JP2738540B2 (hu)
KR (1) KR970002659B1 (hu)
AT (4) ATE217009T1 (hu)
CA (1) CA1324128C (hu)
DE (4) DE3856477T2 (hu)
ES (4) ES2157289T3 (hu)
GR (1) GR3026611T3 (hu)
HU (3) HU206886B (hu)
IE (1) IE81131B1 (hu)
IL (1) IL87517A (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (en) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recovery of difluoro sugar
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
WO1997021719A1 (en) 1995-12-13 1997-06-19 Eli Lilly And Company α, α-DIFLUORO-β-HYDROXY THIOL ESTERS AND THEIR SYNTHESIS
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
BRPI0619928A2 (pt) * 2005-12-14 2011-10-25 Dong A Pharm Co Ltd processo de produção de 2', 2'-difluornucleosìdeo e intermediário
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
WO2008117955A1 (en) * 2007-03-23 2008-10-02 Dongwoo Syntech Co., Ltd. Process for preparing of 2'-deoxy-2'2'-difluorocytidine
CN102216314A (zh) * 2008-06-12 2011-10-12 台湾神隆股份有限公司 吉西他滨碱的结晶多晶型物
GB0812895D0 (en) * 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents

Also Published As

Publication number Publication date
IE882608L (en) 1989-02-28
ATE217009T1 (de) 2002-05-15
HU206886B (en) 1993-01-28
ES2113845T3 (es) 1998-05-16
EP0306190B1 (en) 1998-04-08
JP2899577B2 (ja) 1999-06-02
EP0688782A1 (en) 1995-12-27
IE81131B1 (en) 2000-03-22
IL87517A0 (en) 1989-01-31
KR890003794A (ko) 1989-04-18
DE3856330T2 (de) 1999-09-30
ATE164847T1 (de) 1998-04-15
EP0688783B1 (en) 2001-06-13
EP0630905B1 (en) 1999-05-06
ES2176279T3 (es) 2002-12-01
ES2157289T3 (es) 2001-08-16
JP2899576B2 (ja) 1999-06-02
EP0306190A3 (en) 1991-11-21
JP2777359B2 (ja) 1998-07-16
ES2131152T3 (es) 1999-07-16
IL87517A (en) 1993-05-13
DE3856330D1 (de) 1999-06-10
ATE202113T1 (de) 2001-06-15
JP2738540B2 (ja) 1998-04-08
DE3856527D1 (de) 2002-06-06
JP2810034B2 (ja) 1998-10-15
DE3856158D1 (de) 1998-05-14
EP0306190A2 (en) 1989-03-08
EP0630905A1 (en) 1994-12-28
HUT47590A (en) 1989-03-28
JPH1081696A (ja) 1998-03-31
JPS6471894A (en) 1989-03-16
KR970002659B1 (ko) 1997-03-07
HU202249B (en) 1991-02-28
DE3856527T2 (de) 2002-10-31
EP0688783A1 (en) 1995-12-27
JPH1072483A (ja) 1998-03-17
GR3026611T3 (en) 1998-07-31
DE3856158T2 (de) 1998-08-20
ATE179713T1 (de) 1999-05-15
HU906268D0 (en) 1991-03-28
JPH1072457A (ja) 1998-03-17
EP0688782B1 (en) 2002-05-02
DE3856477D1 (de) 2001-07-19
JPH1072484A (ja) 1998-03-17
CA1324128C (en) 1993-11-09
DE3856477T2 (de) 2001-11-08

Similar Documents

Publication Publication Date Title
HU9201768D0 (en) New process for the selective isolation of 2-deoxi-2,2-difluor-d-eritro-pentfuranose-1-ulose-3,5-dibensoate from enantiomeric solution
MY103514A (en) Process for production of a avermectins and cultures therefor.
MY102581A (en) Process for production of avermectins and cultures therefor
EP0187680A3 (en) Process for producing organic acids by use of microorganisms
HUT47114A (en) Process for producing podophyllotoxin and podophyllotoxin derivatives
HUT45727A (en) Process for production of vinilchlorid by thermic splitting of 1,2-dichlor-ethan
HUT44788A (en) Process for production of new imidazo- triazolo-1,4-benzodiazepins
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
HUT43792A (en) Process for production of combined vaccine
HUT47600A (en) Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them
GB2214914B (en) Method for production of glucose by use of transglucosidase
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
EP0313297A3 (en) Process for production of avermectin aglycones and cultures therefor
HUT47912A (en) Process for production of derivatives of 1-acyl-2,3-dihydro-4/1h/-quinoline-4-oxim and medical compositions containing these substances
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
CS476288A2 (en) Method of 3-(3-pyridyle)-1h,3h-pyrrolo (1,2-0)-thiazole-7-carboxylic dextrorotary acid production
ATE107631T1 (de) Verfahren zur herstellung von indolinon-2- derivaten.
HUT48614A (en) Process for producing desmalonyl derivatives of macrolide lactones
EP0279350A3 (en) Cyclic azepinone and azocinone derivatives, process for their preparation, agents containing them and their use, as well as their intermediates during their production
CA2131284A1 (en) Process for Production of Avermectins and Cultures Therefor
HUT45980A (en) Process for production of derivatives of 5-hidroxi-pgf-below-alpha-1,5-lactone
HUT46366A (en) Process for the microbiological production of 1,2-dehydro-steroids
HUT44496A (en) Improved process for production of 1-methil-piperidine-2-carbonic acid-/-2,6-dimethil-anilid/
CS786187A1 (en) Method of combined tanning agent production